Skip to content

Precigen PGEN Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
25M0.0%
ALN
Alnylam PharmaceuticalsALNY
5M0.0%
Merck & Co. logo
Merck & Co.MRK
20M0.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
10M0.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's convertible preferred stock authorized shares?
Precigen (PGEN) reported convertible preferred stock authorized shares of 25M in Q1 2026.
How has Precigen's convertible preferred stock authorized shares changed year-over-year?
Precigen's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 25M to 25M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.